nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—Cystitis noninfective—Epirubicin—testicular cancer	0.00242	0.00242	CcSEcCtD
Lorazepam—Coma—Methotrexate—testicular cancer	0.00242	0.00242	CcSEcCtD
Lorazepam—Jaundice—Etoposide—testicular cancer	0.00241	0.00241	CcSEcCtD
Lorazepam—Salivary hypersecretion—Epirubicin—testicular cancer	0.0024	0.0024	CcSEcCtD
Lorazepam—Bladder pain—Methotrexate—testicular cancer	0.00239	0.00239	CcSEcCtD
Lorazepam—Cystitis—Epirubicin—testicular cancer	0.00239	0.00239	CcSEcCtD
Lorazepam—Pain—Vinblastine—testicular cancer	0.00236	0.00236	CcSEcCtD
Lorazepam—Constipation—Vinblastine—testicular cancer	0.00236	0.00236	CcSEcCtD
Lorazepam—Atrioventricular block—Doxorubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Lorazepam—Pulmonary oedema—Methotrexate—testicular cancer	0.00235	0.00235	CcSEcCtD
Lorazepam—Confusional state—Bleomycin—testicular cancer	0.00235	0.00235	CcSEcCtD
Lorazepam—Visual impairment—Cisplatin—testicular cancer	0.00233	0.00233	CcSEcCtD
Lorazepam—Infection—Bleomycin—testicular cancer	0.00232	0.00232	CcSEcCtD
Lorazepam—Agranulocytosis—Etoposide—testicular cancer	0.00231	0.00231	CcSEcCtD
Lorazepam—Vision blurred—Ifosfamide—testicular cancer	0.0023	0.0023	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Doxorubicin—testicular cancer	0.00229	0.00229	CcSEcCtD
Lorazepam—Hepatocellular injury—Doxorubicin—testicular cancer	0.00229	0.00229	CcSEcCtD
Lorazepam—Thrombocytopenia—Bleomycin—testicular cancer	0.00229	0.00229	CcSEcCtD
Lorazepam—Feeling abnormal—Vinblastine—testicular cancer	0.00228	0.00228	CcSEcCtD
Lorazepam—Injection site reaction—Doxorubicin—testicular cancer	0.00228	0.00228	CcSEcCtD
Lorazepam—Coma—Epirubicin—testicular cancer	0.00226	0.00226	CcSEcCtD
Lorazepam—Agitation—Ifosfamide—testicular cancer	0.00225	0.00225	CcSEcCtD
Lorazepam—Bladder pain—Epirubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Lorazepam—Cystitis noninfective—Doxorubicin—testicular cancer	0.00224	0.00224	CcSEcCtD
Lorazepam—Salivary hypersecretion—Doxorubicin—testicular cancer	0.00222	0.00222	CcSEcCtD
Lorazepam—Hypersensitivity—Chlorambucil—testicular cancer	0.00222	0.00222	CcSEcCtD
Lorazepam—Cystitis—Doxorubicin—testicular cancer	0.00221	0.00221	CcSEcCtD
Lorazepam—Pulmonary oedema—Epirubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Lorazepam—Vertigo—Ifosfamide—testicular cancer	0.0022	0.0022	CcSEcCtD
Lorazepam—Hypotension—Bleomycin—testicular cancer	0.00218	0.00218	CcSEcCtD
Lorazepam—Asthenia—Chlorambucil—testicular cancer	0.00216	0.00216	CcSEcCtD
Lorazepam—Infection—Dactinomycin—testicular cancer	0.00216	0.00216	CcSEcCtD
Lorazepam—Arrhythmia—Cisplatin—testicular cancer	0.00216	0.00216	CcSEcCtD
Lorazepam—Mental disability—Epirubicin—testicular cancer	0.00215	0.00215	CcSEcCtD
Lorazepam—Alopecia—Cisplatin—testicular cancer	0.00214	0.00214	CcSEcCtD
Lorazepam—Thrombocytopenia—Dactinomycin—testicular cancer	0.00213	0.00213	CcSEcCtD
Lorazepam—Convulsion—Ifosfamide—testicular cancer	0.00212	0.00212	CcSEcCtD
Lorazepam—Hypertension—Ifosfamide—testicular cancer	0.00211	0.00211	CcSEcCtD
Lorazepam—Erythema—Cisplatin—testicular cancer	0.00211	0.00211	CcSEcCtD
Lorazepam—Coma—Doxorubicin—testicular cancer	0.00209	0.00209	CcSEcCtD
Lorazepam—Bladder pain—Doxorubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.00207	0.00207	CcSEcCtD
Lorazepam—Pulmonary oedema—Doxorubicin—testicular cancer	0.00204	0.00204	CcSEcCtD
Lorazepam—Hypersensitivity—Vinblastine—testicular cancer	0.00204	0.00204	CcSEcCtD
Lorazepam—Visual disturbance—Methotrexate—testicular cancer	0.00203	0.00203	CcSEcCtD
Lorazepam—Confusional state—Ifosfamide—testicular cancer	0.00201	0.00201	CcSEcCtD
Lorazepam—Pain—Bleomycin—testicular cancer	0.002	0.002	CcSEcCtD
Lorazepam—Chills—Etoposide—testicular cancer	0.00199	0.00199	CcSEcCtD
Lorazepam—Mental disability—Doxorubicin—testicular cancer	0.00199	0.00199	CcSEcCtD
Lorazepam—Vision blurred—Cisplatin—testicular cancer	0.00199	0.00199	CcSEcCtD
Lorazepam—Asthenia—Vinblastine—testicular cancer	0.00198	0.00198	CcSEcCtD
Lorazepam—Infection—Ifosfamide—testicular cancer	0.00198	0.00198	CcSEcCtD
Lorazepam—Tremor—Cisplatin—testicular cancer	0.00197	0.00197	CcSEcCtD
Lorazepam—Alopecia—Etoposide—testicular cancer	0.00196	0.00196	CcSEcCtD
Lorazepam—Lethargy—Methotrexate—testicular cancer	0.00196	0.00196	CcSEcCtD
Lorazepam—Thrombocytopenia—Ifosfamide—testicular cancer	0.00195	0.00195	CcSEcCtD
Lorazepam—Feeling abnormal—Bleomycin—testicular cancer	0.00192	0.00192	CcSEcCtD
Lorazepam—Osteoarthritis—Methotrexate—testicular cancer	0.00192	0.00192	CcSEcCtD
Lorazepam—Vomiting—Chlorambucil—testicular cancer	0.00192	0.00192	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.00191	0.00191	CcSEcCtD
Lorazepam—Fatigue—Dactinomycin—testicular cancer	0.00188	0.00188	CcSEcCtD
Lorazepam—Hypotension—Ifosfamide—testicular cancer	0.00186	0.00186	CcSEcCtD
Lorazepam—Pain—Dactinomycin—testicular cancer	0.00186	0.00186	CcSEcCtD
Lorazepam—Lethargy—Epirubicin—testicular cancer	0.00183	0.00183	CcSEcCtD
Lorazepam—Irritability—Methotrexate—testicular cancer	0.00183	0.00183	CcSEcCtD
Lorazepam—Dizziness—Vinblastine—testicular cancer	0.00183	0.00183	CcSEcCtD
Lorazepam—Convulsion—Cisplatin—testicular cancer	0.00183	0.00183	CcSEcCtD
Lorazepam—Ataxia—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Lorazepam—Hyponatraemia—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Lorazepam—Osteoarthritis—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Lorazepam—Diplopia—Epirubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Lorazepam—Feeling abnormal—Dactinomycin—testicular cancer	0.00179	0.00179	CcSEcCtD
Lorazepam—Nausea—Chlorambucil—testicular cancer	0.00179	0.00179	CcSEcCtD
Lorazepam—Somnolence—Ifosfamide—testicular cancer	0.00177	0.00177	CcSEcCtD
Lorazepam—Liver function test abnormal—Methotrexate—testicular cancer	0.00177	0.00177	CcSEcCtD
Lorazepam—Vomiting—Vinblastine—testicular cancer	0.00176	0.00176	CcSEcCtD
Lorazepam—Vertigo—Etoposide—testicular cancer	0.00173	0.00173	CcSEcCtD
Lorazepam—Headache—Vinblastine—testicular cancer	0.00173	0.00173	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00172	0.00172	CcSEcCtD
Lorazepam—Fatigue—Ifosfamide—testicular cancer	0.00172	0.00172	CcSEcCtD
Lorazepam—Hypersensitivity—Bleomycin—testicular cancer	0.00172	0.00172	CcSEcCtD
Lorazepam—Cardiac arrest—Epirubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Lorazepam—Infection—Cisplatin—testicular cancer	0.00171	0.00171	CcSEcCtD
Lorazepam—Pain—Ifosfamide—testicular cancer	0.00171	0.00171	CcSEcCtD
Lorazepam—Constipation—Ifosfamide—testicular cancer	0.00171	0.00171	CcSEcCtD
Lorazepam—Lethargy—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Lorazepam—Ataxia—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Lorazepam—Thrombocytopenia—Cisplatin—testicular cancer	0.00168	0.00168	CcSEcCtD
Lorazepam—Tachycardia—Cisplatin—testicular cancer	0.00168	0.00168	CcSEcCtD
Lorazepam—Asthenia—Bleomycin—testicular cancer	0.00167	0.00167	CcSEcCtD
Lorazepam—Convulsion—Etoposide—testicular cancer	0.00167	0.00167	CcSEcCtD
Lorazepam—Hyponatraemia—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Lorazepam—Hypertension—Etoposide—testicular cancer	0.00167	0.00167	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Lorazepam—Osteoarthritis—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Lorazepam—Diplopia—Doxorubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Lorazepam—Liver function test abnormal—Epirubicin—testicular cancer	0.00166	0.00166	CcSEcCtD
Lorazepam—Feeling abnormal—Ifosfamide—testicular cancer	0.00164	0.00164	CcSEcCtD
Lorazepam—Nausea—Vinblastine—testicular cancer	0.00164	0.00164	CcSEcCtD
Lorazepam—Hypotension—Cisplatin—testicular cancer	0.00161	0.00161	CcSEcCtD
Lorazepam—Hypersensitivity—Dactinomycin—testicular cancer	0.0016	0.0016	CcSEcCtD
Lorazepam—Confusional state—Etoposide—testicular cancer	0.00159	0.00159	CcSEcCtD
Lorazepam—Cardiac arrest—Doxorubicin—testicular cancer	0.00158	0.00158	CcSEcCtD
Lorazepam—Pancytopenia—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Lorazepam—Infection—Etoposide—testicular cancer	0.00157	0.00157	CcSEcCtD
Lorazepam—Ataxia—Doxorubicin—testicular cancer	0.00156	0.00156	CcSEcCtD
Lorazepam—Asthenia—Dactinomycin—testicular cancer	0.00156	0.00156	CcSEcCtD
Lorazepam—Thrombocytopenia—Etoposide—testicular cancer	0.00154	0.00154	CcSEcCtD
Lorazepam—Tachycardia—Etoposide—testicular cancer	0.00154	0.00154	CcSEcCtD
Lorazepam—Liver function test abnormal—Doxorubicin—testicular cancer	0.00154	0.00154	CcSEcCtD
Lorazepam—Erectile dysfunction—Methotrexate—testicular cancer	0.00153	0.00153	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00148	0.00148	CcSEcCtD
Lorazepam—Vomiting—Bleomycin—testicular cancer	0.00148	0.00148	CcSEcCtD
Lorazepam—Drowsiness—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Lorazepam—Pancytopenia—Epirubicin—testicular cancer	0.00147	0.00147	CcSEcCtD
Lorazepam—Hypotension—Etoposide—testicular cancer	0.00147	0.00147	CcSEcCtD
Lorazepam—Rash—Bleomycin—testicular cancer	0.00147	0.00147	CcSEcCtD
Lorazepam—Pain—Cisplatin—testicular cancer	0.00147	0.00147	CcSEcCtD
Lorazepam—Dermatitis—Bleomycin—testicular cancer	0.00147	0.00147	CcSEcCtD
Lorazepam—Hypersensitivity—Ifosfamide—testicular cancer	0.00147	0.00147	CcSEcCtD
Lorazepam—Asthenia—Ifosfamide—testicular cancer	0.00143	0.00143	CcSEcCtD
Lorazepam—Feeling abnormal—Cisplatin—testicular cancer	0.00142	0.00142	CcSEcCtD
Lorazepam—Somnolence—Etoposide—testicular cancer	0.0014	0.0014	CcSEcCtD
Lorazepam—Nausea—Bleomycin—testicular cancer	0.00139	0.00139	CcSEcCtD
Lorazepam—Drowsiness—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Lorazepam—Vomiting—Dactinomycin—testicular cancer	0.00138	0.00138	CcSEcCtD
Lorazepam—Agranulocytosis—Methotrexate—testicular cancer	0.00138	0.00138	CcSEcCtD
Lorazepam—Rash—Dactinomycin—testicular cancer	0.00137	0.00137	CcSEcCtD
Lorazepam—Pancytopenia—Doxorubicin—testicular cancer	0.00136	0.00136	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Etoposide—testicular cancer	0.00136	0.00136	CcSEcCtD
Lorazepam—Fatigue—Etoposide—testicular cancer	0.00136	0.00136	CcSEcCtD
Lorazepam—Jaundice—Epirubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Lorazepam—Pain—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Lorazepam—Constipation—Etoposide—testicular cancer	0.00135	0.00135	CcSEcCtD
Lorazepam—Dizziness—Ifosfamide—testicular cancer	0.00132	0.00132	CcSEcCtD
Lorazepam—Feeling abnormal—Etoposide—testicular cancer	0.0013	0.0013	CcSEcCtD
Lorazepam—Nausea—Dactinomycin—testicular cancer	0.00129	0.00129	CcSEcCtD
Lorazepam—Agranulocytosis—Epirubicin—testicular cancer	0.00129	0.00129	CcSEcCtD
Lorazepam—Drowsiness—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Lorazepam—Visual impairment—Methotrexate—testicular cancer	0.00128	0.00128	CcSEcCtD
Lorazepam—Vomiting—Ifosfamide—testicular cancer	0.00127	0.00127	CcSEcCtD
Lorazepam—Hypersensitivity—Cisplatin—testicular cancer	0.00127	0.00127	CcSEcCtD
Lorazepam—Bradycardia—Epirubicin—testicular cancer	0.00127	0.00127	CcSEcCtD
Lorazepam—Rash—Ifosfamide—testicular cancer	0.00126	0.00126	CcSEcCtD
Lorazepam—Dermatitis—Ifosfamide—testicular cancer	0.00126	0.00126	CcSEcCtD
Lorazepam—Jaundice—Doxorubicin—testicular cancer	0.00125	0.00125	CcSEcCtD
Lorazepam—Asthenia—Cisplatin—testicular cancer	0.00123	0.00123	CcSEcCtD
Lorazepam—Visual impairment—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Lorazepam—Agranulocytosis—Doxorubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Lorazepam—Chills—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Lorazepam—Nausea—Ifosfamide—testicular cancer	0.00118	0.00118	CcSEcCtD
Lorazepam—Alopecia—Methotrexate—testicular cancer	0.00117	0.00117	CcSEcCtD
Lorazepam—Bradycardia—Doxorubicin—testicular cancer	0.00117	0.00117	CcSEcCtD
Lorazepam—Hypersensitivity—Etoposide—testicular cancer	0.00116	0.00116	CcSEcCtD
Lorazepam—Erythema—Methotrexate—testicular cancer	0.00116	0.00116	CcSEcCtD
Lorazepam—Asthenia—Etoposide—testicular cancer	0.00113	0.00113	CcSEcCtD
Lorazepam—Chills—Epirubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Lorazepam—Arrhythmia—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Lorazepam—Visual impairment—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Lorazepam—Alopecia—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Lorazepam—Vomiting—Cisplatin—testicular cancer	0.00109	0.00109	CcSEcCtD
Lorazepam—Vision blurred—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Lorazepam—Rash—Cisplatin—testicular cancer	0.00108	0.00108	CcSEcCtD
Lorazepam—Dermatitis—Cisplatin—testicular cancer	0.00108	0.00108	CcSEcCtD
Lorazepam—Erythema—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Lorazepam—Tension—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Lorazepam—Nervousness—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Lorazepam—Dizziness—Etoposide—testicular cancer	0.00104	0.00104	CcSEcCtD
Lorazepam—Vertigo—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Lorazepam—Chills—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Lorazepam—Arrhythmia—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Lorazepam—Nausea—Cisplatin—testicular cancer	0.00102	0.00102	CcSEcCtD
Lorazepam—Vision blurred—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Lorazepam—Alopecia—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Lorazepam—Convulsion—Methotrexate—testicular cancer	0.001	0.001	CcSEcCtD
Lorazepam—Vomiting—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Lorazepam—Erythema—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Lorazepam—Agitation—Epirubicin—testicular cancer	0.000995	0.000995	CcSEcCtD
Lorazepam—Rash—Etoposide—testicular cancer	0.000993	0.000993	CcSEcCtD
Lorazepam—Dermatitis—Etoposide—testicular cancer	0.000993	0.000993	CcSEcCtD
Lorazepam—Headache—Etoposide—testicular cancer	0.000987	0.000987	CcSEcCtD
Lorazepam—Tension—Doxorubicin—testicular cancer	0.000983	0.000983	CcSEcCtD
Lorazepam—Nervousness—Doxorubicin—testicular cancer	0.000973	0.000973	CcSEcCtD
Lorazepam—Vertigo—Epirubicin—testicular cancer	0.000972	0.000972	CcSEcCtD
Lorazepam—Confusional state—Methotrexate—testicular cancer	0.000952	0.000952	CcSEcCtD
Lorazepam—Vision blurred—Doxorubicin—testicular cancer	0.000944	0.000944	CcSEcCtD
Lorazepam—Convulsion—Epirubicin—testicular cancer	0.000938	0.000938	CcSEcCtD
Lorazepam—Infection—Methotrexate—testicular cancer	0.000938	0.000938	CcSEcCtD
Lorazepam—Nausea—Etoposide—testicular cancer	0.000936	0.000936	CcSEcCtD
Lorazepam—Hypertension—Epirubicin—testicular cancer	0.000934	0.000934	CcSEcCtD
Lorazepam—Thrombocytopenia—Methotrexate—testicular cancer	0.000924	0.000924	CcSEcCtD
Lorazepam—Agitation—Doxorubicin—testicular cancer	0.00092	0.00092	CcSEcCtD
Lorazepam—Dry mouth—Epirubicin—testicular cancer	0.000901	0.000901	CcSEcCtD
Lorazepam—Vertigo—Doxorubicin—testicular cancer	0.0009	0.0009	CcSEcCtD
Lorazepam—Confusional state—Epirubicin—testicular cancer	0.000891	0.000891	CcSEcCtD
Lorazepam—Hypotension—Methotrexate—testicular cancer	0.000882	0.000882	CcSEcCtD
Lorazepam—Infection—Epirubicin—testicular cancer	0.000877	0.000877	CcSEcCtD
Lorazepam—Convulsion—Doxorubicin—testicular cancer	0.000868	0.000868	CcSEcCtD
Lorazepam—Thrombocytopenia—Epirubicin—testicular cancer	0.000865	0.000865	CcSEcCtD
Lorazepam—Hypertension—Doxorubicin—testicular cancer	0.000865	0.000865	CcSEcCtD
Lorazepam—Tachycardia—Epirubicin—testicular cancer	0.000862	0.000862	CcSEcCtD
Lorazepam—Somnolence—Methotrexate—testicular cancer	0.000839	0.000839	CcSEcCtD
Lorazepam—Dry mouth—Doxorubicin—testicular cancer	0.000834	0.000834	CcSEcCtD
Lorazepam—Hypotension—Epirubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Lorazepam—Confusional state—Doxorubicin—testicular cancer	0.000824	0.000824	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000815	0.000815	CcSEcCtD
Lorazepam—Fatigue—Methotrexate—testicular cancer	0.000814	0.000814	CcSEcCtD
Lorazepam—Infection—Doxorubicin—testicular cancer	0.000812	0.000812	CcSEcCtD
Lorazepam—Pain—Methotrexate—testicular cancer	0.000807	0.000807	CcSEcCtD
Lorazepam—Thrombocytopenia—Doxorubicin—testicular cancer	0.0008	0.0008	CcSEcCtD
Lorazepam—Tachycardia—Doxorubicin—testicular cancer	0.000798	0.000798	CcSEcCtD
Lorazepam—Somnolence—Epirubicin—testicular cancer	0.000785	0.000785	CcSEcCtD
Lorazepam—Feeling abnormal—Methotrexate—testicular cancer	0.000778	0.000778	CcSEcCtD
Lorazepam—Hypotension—Doxorubicin—testicular cancer	0.000764	0.000764	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Lorazepam—Fatigue—Epirubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Lorazepam—Pain—Epirubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Lorazepam—Constipation—Epirubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Lorazepam—Feeling abnormal—Epirubicin—testicular cancer	0.000728	0.000728	CcSEcCtD
Lorazepam—Somnolence—Doxorubicin—testicular cancer	0.000727	0.000727	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000706	0.000706	CcSEcCtD
Lorazepam—Fatigue—Doxorubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Lorazepam—Pain—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Lorazepam—Constipation—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Lorazepam—Hypersensitivity—Methotrexate—testicular cancer	0.000695	0.000695	CcSEcCtD
Lorazepam—Asthenia—Methotrexate—testicular cancer	0.000677	0.000677	CcSEcCtD
Lorazepam—Feeling abnormal—Doxorubicin—testicular cancer	0.000673	0.000673	CcSEcCtD
Lorazepam—Hypersensitivity—Epirubicin—testicular cancer	0.000651	0.000651	CcSEcCtD
Lorazepam—Asthenia—Epirubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Lorazepam—Dizziness—Methotrexate—testicular cancer	0.000624	0.000624	CcSEcCtD
Lorazepam—Hypersensitivity—Doxorubicin—testicular cancer	0.000602	0.000602	CcSEcCtD
Lorazepam—Vomiting—Methotrexate—testicular cancer	0.0006	0.0006	CcSEcCtD
Lorazepam—Rash—Methotrexate—testicular cancer	0.000595	0.000595	CcSEcCtD
Lorazepam—Dermatitis—Methotrexate—testicular cancer	0.000595	0.000595	CcSEcCtD
Lorazepam—Headache—Methotrexate—testicular cancer	0.000591	0.000591	CcSEcCtD
Lorazepam—Asthenia—Doxorubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Lorazepam—Dizziness—Epirubicin—testicular cancer	0.000584	0.000584	CcSEcCtD
Lorazepam—Vomiting—Epirubicin—testicular cancer	0.000562	0.000562	CcSEcCtD
Lorazepam—Nausea—Methotrexate—testicular cancer	0.000561	0.000561	CcSEcCtD
Lorazepam—Rash—Epirubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Lorazepam—Dermatitis—Epirubicin—testicular cancer	0.000556	0.000556	CcSEcCtD
Lorazepam—Headache—Epirubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Lorazepam—Dizziness—Doxorubicin—testicular cancer	0.00054	0.00054	CcSEcCtD
Lorazepam—Nausea—Epirubicin—testicular cancer	0.000525	0.000525	CcSEcCtD
Lorazepam—Vomiting—Doxorubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Lorazepam—Rash—Doxorubicin—testicular cancer	0.000515	0.000515	CcSEcCtD
Lorazepam—Dermatitis—Doxorubicin—testicular cancer	0.000515	0.000515	CcSEcCtD
Lorazepam—Headache—Doxorubicin—testicular cancer	0.000512	0.000512	CcSEcCtD
Lorazepam—Nausea—Doxorubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
